News

Oxford Instruments plc has acquired Medical Imaging Resources Inc. (MIR). MIR specializes in the build, lease and service of mobile medical imaging labs.

Home May 28, 2015
Home
News

CVRx Inc. announced that positive results from the 'Barostim Therapy for Heart Failure' randomized, controlled clinical trial were presented at the ESC-Heart Failure 2015 Annual Conference in a late-breaking trial session. Results were presented by Prof. Jochen MĂĽller-Ehmsen, M.D., Ph.D., from Asklepios Hospital Altona in Hamburg, Germany.

Home May 28, 2015
Home
electronic stents, bioresorbable electronic stent, BES
Feature | Stents | Dave Fornell

With the recent innovation of flexible microelectronic sensor circuits that can be made from bioresorbable materials, it is now possible to create “electronic stents” to monitor a treated lesion site inside a patient’s artery. A Korean-led team recently published their research on the first device of this kind, showing proof of concept in the American Chemical Society journal ACS Nano.[1]

Home May 28, 2015
Home
Technology

The U.S. Food and Drug Administration (FDA) has cleared the InvisionECG technology from InvisionHeart. The mobile electrocardiogram (ECG) technology uses a secure cloud-based, healthcare IT platform to capture and manage 12-lead ECGs.

Home May 28, 2015
Home
CyberHeart, Stony Brook, NSF grant, $4.2 million, Scott Smolka
Feature

A virtual-heart platform proposed by Stony Brook University researchers and colleagues has received funding from the National Science Foundation (NSF) in the amount of $4.2 million over five years. The platform was designed to improve and accelerate medical-device development and testing.

Home May 28, 2015
Home
News

OrbusNeich has announced that the first U.S. patient has been enrolled in the HARMONEE (Harmonized Assessment by Randomized, Multi-center Study of OrbusNEich's COMBO StEnt) stent study. The study is being conducted under the framework of the joint Japan-U.S. Harmonization-By-Doing (HBD) initiative and will support the company's planned application for Shonin approval in Japan and to meet the feasibility trial requirements in the U.S.

Home May 28, 2015
Home
News | Wearables

Kareo announced the launch of its Apple Watch App. This most recent innovation extends the functionality of the company’s electronic health record (EHR) to Apple Watch, streamlining care delivery and enhancing the patient experience by improving communications, reducing patient wait times and increasing practice efficiency.

Home May 27, 2015
Home
Technology

Medic Vision Imaging Solutions Ltd. announced the introduction and availability of SafeCT Dose Reporting. Healthcare facilities can now, for the first time, use a single software platform to meet their low dose computed tomography (CT) imaging needs while also conforming to CT dose monitoring and reporting standards.

Home May 27, 2015
Home
News

A microsupercapacitor designed by scientists at Rice University that may find its way into personal and even wearable electronics is getting an upgrade. The laser-induced graphene device benefits greatly when boron becomes part of the mix.

Home May 27, 2015
Home
Shockwave Medical, Lithoplasty, $40 million, funding, Sofinnova, Venrock
Feature

Shockwave Medical announced $40 million in funding, co-led by returning investor Sofinnova Partners and new investor Venrock. Also participating were RA Capital, Deerfield, Sectoral Asset Management, Ally Bridge Group and two undisclosed large-cap strategic investors.

Home May 27, 2015
Home
News

Dassault Systèmes announced during its SIMULIA Community Conference that the first heart model from its “Living Heart Project” will be commercially available on May 29, 2015. Powered by Dassault Systèmes’ 3DEXPERIENCE platform’s realistic simulation applications, the commercial, high-fidelity, scientifically validated 3-D simulator of a four-chamber human heart is the first product of its kind. With this model, device manufacturers, researchers and medical professionals will be able to perform virtual tests and visualize the heart’s response in ways that are not possible with traditional physical testing.

Home May 27, 2015
Home
News

A new study evaluating the Boston Scientific Lotus Valve System demonstrated an extremely low rate of paravalvular aortic regurgitation (leakage) for a transcatheter aortic replacement valve. Study data also showed a cardiovascular mortality rate of less than 2 percent at 30 days.

Home May 27, 2015
Home
ART, PBS, pure bioresorbable scaffold, CE Mark
Feature

Privately-held company Arterial Remodeling Technologies (ART) announced CE Mark clearance for its next-generation drug-free, pure bioresorbable scaffold used to treat coronary artery disease. The CE Mark was achieved following the completion of extensive pre-clinical research — this included up to three-years of follow-up, and supportive clinical results from leading coronary angioplasty centres such as the Hôpital Européen Georges Pompidou in Paris and investigators such as Jean Fajadet, M.D., at the Clinique Pasteur in Toulouse.

Home May 26, 2015
Home
Feature

At EuroPCR 2015, Mitralign presented updates on its mitral and tricuspid valve repair systems, including a presentation on six-month data on its Mitral system.

Home May 26, 2015
Home
News

Edwards Lifesciences Corp. announced that 30-day outcomes for intermediate-risk patients treated transfemorally with the SAPIEN 3 transcatheter aortic valve demonstrated very low mortality and stroke rates, and no severe paravalvular leaks. These independently adjudicated data from centers in Europe and Canada are consistent with the outcomes recently reported in a similar study of 1,000 patients treated at 51 centers in the United States. The study was presented at EuroPCR 2015 by Alec Vahanian, M.D., chair of the cardiology department at Bichat University Hospital, Paris.

Home May 26, 2015
Home
Subscribe Now